MicroRNA-340在肝细胞肝癌中抑制细胞增殖并促进凋亡
CSTR:
作者:
作者单位:

重庆医科大学附属第一医院肝胆外科,重庆医科大学附属第一医院肝胆外科,重庆医科大学附属第一医院肝胆外科

作者简介:

通讯作者:

中图分类号:

基金项目:

重庆市科委科技计划项目(cstc2015shmszx120039).


MicroRNA-340 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma
Author:
Affiliation:

Department of Hepatobiliary Surgery,The First Affiliated Hospital of Chongqing Medical University,Chongqing Medical University,Department of Hepatobiliary Surgery,The First Affiliated Hospital of Chongqing Medical University,Chongqing Medical University,Department of Hepatobiliary Surgery,The First Affiliated Hospital of Chongqing Medical University,Chongqing Medical University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨微RNA-340(miR-340)在肝细胞肝癌中的表达特点及其对细胞生物学行为的影响。方法 收集重庆医科大学附属第一医院肝胆外科2015年3月至2016年9月收治的40例肝细胞肝癌患者手术后切除的癌组织和癌旁组织标本。通过qPCR检测组织标本中miR-340的表达,并分析miR-340表达与临床病理学指标的关系。分别培养肝癌细胞株Hep3B、Bel-7402、HepG2和SMMC-7721以及正常肝细胞株HL-7702,48 h后使用qPCR检测5种细胞中miR-340的表达水平。通过转染增加或抑制SMMC-7721细胞中miR-340的表达,然后分别于细胞培养24、48、72 h后采用CCK-8法检测SMMC-7721细胞增殖,流式细胞术检测细胞凋亡。通过生物信息学软件预测miR-340的靶基因,并使用qPCR和蛋白质印迹法进一步验证miR-340对靶基因的作用。结果 癌组织中miR-340的表达低于癌旁组织(P<0.01),并且miR-340的表达与乙肝表面抗原、HBV DNA载量、肿瘤大小以及临床TNM分期有关(P<0.01)。正常肝细胞HL-7702内miR-340的表达高于4种肝癌细胞Hep3B、Bel-7402、HepG2和SMMC-7721(P<0.05,P<0.01)。增加miR-340表达可抑制SMMC-7721细胞的增殖(P<0.05,P<0.01),而抑制miR-340的表达则促进SMMC-7721细胞的增殖(P<0.05,P<0.01);增加miR-340的表达可促进SMMC-7721细胞的凋亡(P<0.01),而抑制miR-340则减少凋亡(P<0.01)。生物信息学分析显示S期激酶相关蛋白2(SKP2)基因是miR-340下游的一个靶基因。qPCR和蛋白质印迹分析结果显示增加SMMC-7721细胞中miR-340的表达可抑制SKP2的mRNA和蛋白表达,抑制miR-340表达则增加SKP2的mRNA和蛋白表达。结论 miR-340的异常表达可能与乙肝病毒的感染有关,其异常表达有助于评价病情以及预后。在肝癌细胞系SMMC-7721细胞中,miR-340能够抑制细胞增殖并促进凋亡,这一作用结果可能是通过miR-340对SKP2的抑制而实现的。

    Abstract:

    Objective To investigate the expression of microRNA-340 (miR-340) in hepatocellular carcinoma (HCC) and its effect on cell biological behavior. Methods We collected 40 frozen HCC tissues and adjacent non-tumor tissues from patients undergoing hepatectomy of HCC at The First Affiliated Hospital of Chongqing Medical University from Mar. 2015 to Sep. 2016. The expression of miR-340 in all tissues was detected by qPCR and the relationship between miR-340 expression and clinicopathological parameters was analyzed. Simultaneously, the expression of miR-340 in normal hepatocyte (HL-7702) and four hepatoma cells lines (Hep3B, Bel-7402, HepG2, SMMC-7721) was detected by qPCR after incubation for 48 h. The eukaryotic expression vector with miR-340 or control reagent was transfected into SMMC-7721 cells using EndoFectionTM-Max to increase or inhibit the expression of miR-340, and then the cells were cultured for 24 h, 48 h and 72 h. The proliferation of SMMC-7721 cells was detected by CCK-8 assay, and the apoptosis was detected by flow cytometry. The target gene of miR-340 was predicted by bioinformatics software, and the effect of miR-340 on target gene was further verified by qPCR and Western blotting. Results The expression of miR-340 in HCC tissues was significantly lower than that in the adjacent non-tumor tissues (P<0.01), and was correlated with hepatitis B surface antigen, HBV DNA, tumor size and TNM stage (all P<0.01). Besides, the expression of miR-340 in HL-7702 cells was significantly higher than that in Hep3B, Bel-7402, HepG2 and SMMC-7721 cells (P<0.05, P<0.01). CCK-8 assay results showed that overexpression of miR-340 inhibited proliferation of SMMC-7721 cells, while inhibition of miR-340 promoted cell proliferation (P<0.05, P<0.01). Overexpression of miR-340 significantly promoted SMMC-7721 cells apoptosis, while suppression of miR-340 significantly inhibited cells apoptosis (all P<0.01). S-phase kinase-associated protein 2 (SKP2) was a target gene of miR-340 as indicated by bioinformatics software. Further, qPCR and Western blotting results showed that overexpression of miR-340 inhibited the mRNA and protein expression of SKP2, while inhibition of miR-340 increased the mRNA and protein expression of SKP2. Conclusion The abnormal expression of miR-340 may be associated with the HBV infection, and miR-340 may be an indicator to evaluate the progression and prognosis of HCC. MiR-340 can inhibit proliferation and promote apoptosis of SMMC-7721 cells, which may be effected by inhibiting the SKP2 expression.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2017-03-17
  • 最后修改日期:2017-05-31
  • 录用日期:2017-09-22
  • 在线发布日期: 2017-11-01
  • 出版日期:
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭